2025 annual financial data
Lexaria Bioscience 2025 Operating margin
Direct answer
Operating margin was -1,683.01%.
Operating income was -11,880,737 USD and net income was -11,901,841 USD.
Operating cash flow was -10,450,387 USD.
Get free Lexaria Bioscience email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 705,923 USD
- Operating income
- -11,880,737 USD
- Net income
- -11,901,841 USD
- Operating cash flow
- -10,450,387 USD